Gottesman; Omri

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gottesman; Omri.The latest application filed is for "hsd17b13 variants and uses thereof".

Company Profile

6.7.19

Gottesman; Omri - San Diego CA
Gottesman; Omri - Tarrytown NY
Gottesman; Omri - New York NY
Gottesman; Omri - Rancho Santa Fe CA
Gottesman; Omri - Rancho Sante Fe CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Treatment of thymic stromal lymphopoietin (TSLP) related diseases by inhibition of long-form TSLP transcripts Grant 11,452,738 - Gottesman , et al. September 27, 2	2022-09-27
HSD17B13 Variants And Uses Thereof App 20220267743 - Abul-Husn; Noura S. ; et al.	2022-08-25
Oligonucleotides for treatment of angiopoietin like 4 (ANGPTL4) related diseases Grant 11,377,658 - Gottesman , et al. July 5, 2	2022-07-05
Electronic Phenotyping Technique for Diagnosing Chronic Kidney Disease App 20220084639 - Nadkarni; Girish ; et al.	2022-03-17
Process To Inhibit Or Eliminate Eosinophilic Diseases Of The Airway And Related Conditions App 20220056444 - GOTTESMAN; Omri ; et al.	2022-02-24
Prodrugs Of Alox-15 Inhibitors And Methods Of Using The Same App 20220047612 - GOTTESMAN; Omri ; et al.	2022-02-17
Treatment Of Thymic Stromal Lymphopoietin (tslp) Related Diseases By Inhibition Of Long-form Tslp Transcripts App 20220040220 - GOTTESMAN; Omri ; et al.	2022-02-10
Oligonucleotides For Treatment Of Angiopoietin Like 4 (angptl4) Related Diseases App 20220002731 - GOTTESMAN; Omri ; et al.	2022-01-06
17 -Hydroxysteroid Dehydrogenase Type 13 (HSD17B13) iRNA Compositions And Methods Of Use Thereof App 20210380985 - Hinkle; Gregory ; et al.	2021-12-09
Process To Inhibit Or Eliminate Eosinophilic Diseases Of The Airway And Related Conditions App 20210361693 - BRUSE; Shannon ; et al.	2021-11-25
17.beta.-hydroxysteroid dehydrogenase type 13 (HSD17B13) iRNA compositions and methods of use thereof Grant 11,180,757 - Hinkle , et al. November 23, 2	2021-11-23
Prodrugs of ALOX-15 inhibitors and methods of using the same Grant 11,116,778 - Gottesman , et al. September 14, 2	2021-09-14
Electronic phenotyping technique for diagnosing chronic kidney disease Grant 11,101,021 - Nadkarni , et al. August 24, 2	2021-08-24
Treatment Of Angiopoietin Like 7 (angptl7) Related Diseases App 20210163950 - GOTTESMAN; Omri ; et al.	2021-06-03
Treatment of angiopoietin like 7 (ANGPTL7) related diseases Grant 10,941,404 - Gottesman , et al. March 9, 2	2021-03-09
Prodrugs Of Alox-15 Inhibitors And Methods Of Using The Same App 20210030772 - GOTTESMAN; Omri ; et al.	2021-02-04
Treatment Of Angiopoietin Like 7 (angptl7) Related Diseases App 20200399640 - GOTTESMAN; Omri ; et al.	2020-12-24
Hsd17b13 Variants And Uses Thereof App 20200354693 - Abul-Husn; Noura S. ; et al.	2020-11-12
HSD17B13 variants and uses thereof Grant 10,787,647 - Abul-Husn , et al. September 29, 2	2020-09-29
Treatment And Inhibition Of Inflammatory Lung Diseases In Patients Having Risk Alleles In The Genes Encoding IL33 And IL1RL1 App 20200031922 - BRUSE; Shannon ; et al.	2020-01-30
Hsd17b13 Variants And Uses Thereof App 20180216084 - Abul-Husn; Noura S. ; et al.	2018-08-02
HSD17B13 Variants And Uses Thereof App 20180216104 - Abul-Husn; Noura S. ; et al.	2018-08-02
Genetic Variant-Phenotype Analysis System And Methods Of Use App 20170286594 - Reid; Jeffrey ; et al.	2017-10-05
Automatic Disease Diagnoses Using Longitudinal Medical Record Data App 20170228507 - BOTTINGER; Erwin ; et al.	2017-08-10
Electronic Phenotyping Technique For Diagnosing Chronic Kidney Disease App 20170228506 - Nadkarni; Girish ; et al.	2017-08-10
System and Methods for Personalized Clinical Decision Support Tools App 20140350954 - Ellis; Stephen ; et al.	2014-11-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.